Irish Med-Tech Start-Up Wins US Clearance for AI Software
Published
An Irish medical technology start-up has received clearance from a regulator in the United States for its artificial intelligence (AI) software, according to the Business Post.
In the US, medical devices and software that are used for diagnosis or treatment usually need approval from the Food and Drug Administration (FDA) before they can be sold or used in hospitals and clinics. Clearance allows a company to bring its product to the American market, which is one of the largest healthcare markets in the world.
The report does not give full details of the software or how it works. It also does not say how many customers the company already has or when its product will be available in the United States. Readers who want more information should check the original Business Post article.
The news is a sign of the growing role of Irish companies in the medical technology sector. Ireland has a large number of medical device firms, and many of them export their products to the US and other markets. Clearance for AI products is becoming more common as hospitals look for ways to use technology to support doctors and nurses.
Further updates on the company's plans are expected to follow.
Sources: Business Post
More Ireland news
- Former Silicon Valley Insider Warns US Tech Giants Could Erase Ireland's Gains
- AI Creates New Cybersecurity Opportunities for Irish IT Firms, Research Finds
- Dublin Conference to Address Tech-Facilitated Sexual Violence
- Influencer Boxing Event in Kilkenny Ends in Chaos, Raising Concerns for Tourism
- Nearly 50 European Leaders Gather in Dublin for Major Summit
- Major Traffic Disruption Expected in Dublin as EU-Led Summits Approach
- Plans to Charge Asylum Seekers for Accommodation Delayed as Committee Calls for Contract Review
- Sinn Féin Calls for Referendum on State Pension Triple Lock